M&A Deal Summary

bioMerieux Acquires PML Microbiologicals

On December 8, 2008, bioMerieux acquired life science company PML Microbiologicals from Pelican Life Sciences Group for 30M USD

Acquisition Highlights
  • This is bioMerieux’s 7th transaction in the Life Science sector.
  • This is bioMerieux’s 6th largest (disclosed) transaction.
  • This is bioMerieux’s 5th transaction in the United States.
  • This is bioMerieux’s 1st transaction in Oregon.

M&A Deal Summary
Date 2008-12-08
Target PML Microbiologicals
Sector Life Science
Buyer(s) bioMerieux
Sellers(s) Pelican Life Sciences Group
Deal Type Divestiture
Deal Value 30M USD

Target

PML Microbiologicals

Wilsonville, Oregon, United States
PML Microbiologicals, Inc. is a provider of culture media and microbiological products in North America for both clinical and industrial applications.

Search 199,442 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

bioMerieux

Marcy l'Etoile, France
Category Company
Founded 1963
Sector Life Science
Employees13,409
Revenue 3.7B EUR (2023)
DESCRIPTION

bioMerieux is a provider in the field of in vitro diagnostics. bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy l'Etoile, France.

DEAL STATS #
Overall 10 of 21
Sector (Life Science) 7 of 11
Type (Divestiture) 3 of 3
State (Oregon) 1 of 1
Country (United States) 5 of 8
Year (2008) 3 of 3
Size (of disclosed) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-11 AviaraDX

San Diego, California, United States

AviaraDX, Inc. is a developing and commercializing molecular diagnostic technologies for personalized medicine in cancer treatment.

Buy $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-14 Meikang Biotech

Shanghai, China

Meikang Biotech (Shanghai) Co., Ltd. is a manufacturer of rapid tests products.

Buy -

Seller(S) 1

SELLER

Pelican Life Sciences Group

San Diego, California, United States
Category Company
Sector Life Science
DESCRIPTION

Pelican Life Sciences Group is a provider of diagnostic solutions.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Oregon) 1 of 1
Country (United States) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal